Unbiased assessment of vamorolone for treating Duchenne muscular dystrophy Post author: Post published:January 25, 2024 Post category:uncategorized The drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duchenne muscular dystrophy (DMD). You Might Also Like High-pressure homogenization stabilizes paprika oleoresin September 14, 2024 The role of soy in improving metabolic health August 22, 2024 Study links linoleic acid to triple-negative breast cancer growth April 1, 2025